Improvement of aging-associated cardiovascular dysfunction by the orally administered copper(II)-aspirinate complex

Rejuvenation Research

Volumn 11, Issue 5, 2008, Pages 945-956

  Radovits, Tamás ^a   Gerö, Domokos ^b   Lin, Li Ni ^a   Loganathan, Sivakkanan ^a   Hoppe Tichy, Torsten ^c   Szabó, Csaba ^b,d   Karck, Matthias ^a   Sakurai, Hiromu ^e   Szabó, Gábor ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b SEMMELWEIS UNIVERSITY   (Hungary)

^c UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^d University of Medicine and Dentistry of New Jersey   (United States)

^e KYOTO PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; ACETYLSALICYLATE COPPER; NITROPRUSSIDE SODIUM;

AGING; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ENDOTHELIAL DYSFUNCTION; HEART CATHETER; HEART FUNCTION; HEART LEFT VENTRICLE CONTRACTILITY; HEART LEFT VENTRICLE PRESSURE; HEART LEFT VENTRICLE VOLUME; HEART MUSCLE CONTRACTILITY; HEART VENTRICLE ENDDIASTOLIC PRESSURE; MYOCARDIAL DISEASE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; SYSTOLIC BLOOD PRESSURE; VASCULAR RING; VASODILATATION;

ADMINISTRATION, ORAL; AGING; ANIMALS; ANTIOXIDANTS; ASPIRIN; BASE SEQUENCE; CARDIOVASCULAR SYSTEM; CYCLOOXYGENASE 2; DNA PRIMERS; ENDOTHELIUM, VASCULAR; NITRIC OXIDE SYNTHASE TYPE II; RATS; RATS, INBRED LEW; RNA, MESSENGER;

ANIMALIA; RATTUS;

EID: 54249104519     PISSN: 15491684     EISSN: None     Source Type: Journal    
DOI: 10.1089/rej.2008.0762     Document Type: Article

References (41)

1. Hachamovitch R, Wicker P, Capasso JM, Anversa P. Alterations of coronary blood flow and reserve with aging in Fischer 344 rats. Am J Physiol 1989;256:H66-H73.
2. Tschudi MR, Barton M, Bersinger NA, Moreau P, Cosentino F, Noll G, Malinski T, Lüscher TF. Effect of age on kinetics of nitric oxide release in rat aorta and pulmonary artery. J Clin Invest 1996;98:899-905.
3. Egashira K, Inou T, Hirooka Y, Kai H, Sugimachi M, Suzuki S, Kuga T, Urabe Y, Takeshita A. Effects of age on endothelium-dependent vasodilation of resistance coronary artery by acetylcholine in humans. Circulation 1993;88:77-81.
4. Bejma J, Ramires P, Ji LL. Free radical generation and oxidative stress with aging and exercise: differential effects in the myocardium and liver. Acta Physiol Scand 2000;169:343-351.
5. van der Loo B, Labugger R, Skepper JN, Bachschmid M, Kilo J, Powell JM, Palacios-Callender M, Erusalimsky JD, Quaschning T, Malinski T, Gygi D, Ullrich V, Lüscher TF. Enhanced peroxynitrite formation is associated with vascular aging. J Exp Med 2000;192:1731-1744.
6. Csiszar A, Ungvari Z, Edwards JG, Kaminski P, Wolin MS, Koller A, Kaley G. Aging-induced phenotypic changes and oxidative stress impair coronary arteriolar function. Circ Res 2002;90:1159-1166.
7. Radovits T, Seres L, Gero D, Lin LN, Beller CJ, Chen SH, Zotkina J, Berger I, Groves JT, Szabó C, Szabó G. The peroxynitrite decomposition catalyst FP15 improves ageing-associated cardiac and vascular dysfunction. Mech Ageing Dev 2007;128:173-181.
8. Chung HY, Sung B, Jung KJ, Zou Y, Yu BP. The molecular inflammatory process in aging. Antioxid Redox Signal 2006;8:572-581.
9. Sawada M, Carlson JC. Changes in superoxide radical and lipid peroxide formation in the brain, heart and liver during the lifetime of the rat. Mech Ageing Dev 1987;41:125-137.
10. Sohal RS, Sohal BH. Hydrogen peroxide release by mitochondria increases during aging. Mech Aging Dev 1991;57:187-202.
11. Balaban RS, Nemoto S, Finkel T. Mitochondria, oxidants, and aging. Cell 2005;120:483-495.
12. Ungvári Z, Gupte SA, Recchia FA, Bátkai S, Pacher P. Role of oxidative-nitrosative stress and downstream pathways in various forms of cardiomyopathy and heart failure. Curr Vasc Pharmacol 2005;3:221-229.
13. Csiszar A, Pacher P, Kaley G, Ungvari Z. Role of oxidative and nitrosative stress, longevity genes and poly(ADP-ribose) polymerase in cardiovascular dysfunction associated with aging. Curr Vasc Pharmacol 2005;3:285-291.
14. Virág L, Szabó E, Gergely P, Szabó C. Peroxynitrite-induced cytotoxicity: mechanism and opportunities for intervention. Toxicol Lett 2003;140-141:113-124.
15. Chung HY, Kim HJ, Kim KW, Choi JS, Yu BP. Molecular inflammation hypothesis of aging based on the anti-aging mechanism of calorie restriction. Microsc Res Tech 2002;59:264-272.
16. Chung HY, Kim HJ, Kim JW, Yu BP. The inflammation hypothesis of aging: molecular modulation by calorie restriction. Ann NY Acad Sci 2001;928:327-335.
17. Vasto S, Candore G, Balistreri CR, Caruso M, Colonna-Romano G, Grimaldi MP, Listi F, Nuzzo D, Lio D, Caruso C. Inflammatory networks in ageing, age-related diseases and longevity. Mech Ageing Dev 2007;128:83-91.
18. Kim JW, Baek BS, Kim YK, Herlihy JT, Ikeno Y, Yu BP, Chung HY. Gene expression of cyclooxygenase in the aging heart. J Gerontol A Biol Sci Med Sci 2001;56:B350-B355.
19. Tatchum-Talom R, Martin DS. Tempol improves vascular function in the mesenteric vascular bed of senescent rats. Can J Physiol Pharmacol 2004;82:200-207.
20. Pacher P, Vaslin A, Benko R, Mabley JG, Liaudet L, Haskó G, Marton A, Bátkai S, Kollai M, Szabó C. A new, potent poly(ADP-ribose) polymerase inhibitor improves cardiac and vascular dysfunction associated with advanced aging. J Pharmacol Exp Ther 2004;311:485-491.
21. Radovits T, Seres L, Gero D, Berger I, Szabó C, Karck M, Szabó G. Single dose treatment with PARP-inhibitor INO-1001 improves aging-associated cardiac and vascular dysfunction. Exp Gerontol 2007;42:676-685.
22. Jung KJ, Kim JY, Zou Y, Kim YJ, Yu BP, Chung HY. Effect of short-term, low dose aspirin supplementation on the activation of pro-inflammatory NF-kappaB in aged rats. Mech Ageing Dev 2006;127:223-230.
23. Bulckaen HG, Prevost G, Boulanger E, Robitaille G, Roquet V, Gaxatte C, Garcon G, Corman B, Gosset P, Shirali P, Creusy C, Puisieux F. Low-dose aspirin prevents age-related endothelial dysfunction in a mouse model of physiological aging. Am J Physiol Heart Circ Physiol 2008;294:H1562-H1570.
24. Zhiqiang S, Lei WY, Li L, Chen ZH, Liu WP. Coordination of copper with aspirin improves its anti-inflammatory activity. Inflammopharmacology 1998;6:357-362.
25. Shen ZQ, Liang Y, Chen ZH, Liu WP, Duan L. Effects of copper-aspirin complex on platelet aggregation and thrombosis in rabbits and mice. J Pharm Pharmacol 1998;50:1275-1279.
26. Fujimori T, Yamada S, Yasui H, Sakurai H, In Y, Ishida T. Orally active antioxidative copper(II) aspirinate: synthesis, structure characterization, superoxide scavenging activity, and in vitro and in vivo antioxidative evaluations. J Biol Inorg Chem 2005;10:831-841.
27. Fujimori T, Yasui H, Hiromura M, Sakurai H. Suppressive effect of orally administered copper(II)-aspirinate (Cu2(asp)4) complex on the generation of reactive oxygen species in the skin of animals subjected to UVA exposure. Exp Dermatol 2007;16:746-752.
28. Pacher P, Mabley JG, Liaudet L, Evgenov OV, Marton A, Haskó G, Kollai M, Szabó C. Left ventricular pressure-volume relationship in a rat model of advanced aging-associated heart failure. Am J Physiol Heart Circ Physiol 2004;287:H2132-H2137.
29. Kass DA, Maughan WL, Guo ZM, Kono A, Sunagawa K, Sagawa K. Comparative influence of load versus inotropic states on indexes of ventricular contractility: experimental and theoretical analysis based on pressure-volume relationships. Circulation 1987;76:1422-1436.
30. Sato T, Shishido T, Kawada T, Miyano H, Miyashita H, Inagaki M, Sugimachi M, Sunagawa K. ESPVR of in situ rat left ventricle shows contractility- dependent curvilinearity. Am J Physiol 1998;274:H1429-H1434.
31. Liaudet L, Soriano FG, Szabó E, Virag L, Mabley JG, Salzman AL, Szabó C. Protection against hemorrhagic shock in mice genetically deficient in poly(ADP-ribose)polymerase. Proc Natl Acad Sci USA 2000;97:10203-10208.
32. Harman D. Aging: a theory based on free radical and radiation chemistry. J Gerontol 1956;11:298-300.
33. Kim JD, McCarter RJ, Yu BP. Influence of age, exercise, and dietary restriction on oxidative stress in rats. Aging (Milano) 1996;8:123-129.
34. Xu Y, Armstrong SJ, Arenas IA, Pehowich DJ, Davidge ST. Cardioprotection by chronic estrogen or superoxide dismutase mimetic treatment in the aged female rat. Am J Physiol Heart Circ Physiol 2004;287:H165-H171.
35. Ungvari Z, Orosz Z, Labinskyy N, Rivera A, Xiangmin Z, Smith K, Csiszar A. Increased mitochondrial H2O2 production promotes endothelial NF-kappaB activation in aged rat arteries. Am J Physiol Heart Circ Physiol 2007;293:H37-H47.
36. Davies NM, Sharkey KA, Asfaha S, Macnaughton WK, Wallace JL. Aspirin causes rapid up-regulation of cyclo-oxygenase-2 expression in the stomach of rats. Aliment Pharmacol Ther 1997;11:1101-1108.
37. Pacher P, Mabley JG, Soriano FG, Liaudet L, Komjáti K, Szabó C. Endothelial dysfunction in aging animals: the role of poly(ADP-ribose) polymerase activation. Br J Pharmacol 2002;135:1347-1350.
38. Anversa P, Puntillo E, Nikitin P, Olivetti G, Capasso JM, Sonnenblick EH. Effects of age on mechanical and structural properties of myocardium of Fischer 344 rats. Am J Physiol 1989;256:H1440-H1449.
39. Boluyt MO, Converso K, Hwang HS, Mikkor A, Russell MW. Echocardiographic assessment of age-associated changes in systolic and diastolic function of the female F344 rat heart. J Appl Physiol 2004;96:822-828.
40. Kishore V. Effects of copper aspirinate and aspirin on tissue copper, zinc, and iron concentrations following chronic oral treatment in the adjuvant arthritic rat. Biol Trace Elem Res 1990;25:123-135.
41. Sorenson RJ, Rolniak MT. Preliminary chronic toxicity study of copper aspirinate. Inorganica Chim Acta 1984;91:L31-L34.